Back to search

T-cell depletion of allogeneic bone marrow prevents acceleration of graft-versus-host disease induced by exogenous interleukin 2

Data up to Jan 2025

Published1986
Citations52
References21

Total Citations Per Year

Abstract

References (21)

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples

1977 • 8,468 citations

Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow.

1978 • 524 citations

DEPLETION OF T LYMPHOCYTES IN DONOR MARROW PREVENTS SIGNIFICANT GRAFT-VERSUS-HOST DISEASE IN MATCHED ALLOGENEIC LEUKAEMIC MARROW TRANSPLANT RECIPIENTS

1984 • 362 citations

Does graft-versus-host disease influence the tempo of immunologic recovery after allogeneic human marrow transplantation? An observation on 56 long-term survivors

1978 • 266 citations

In vivo interleukin 2 administration augments the generation of alloreactive cytolytic T lymphocytes and resident natural killer cells.

1983 • 245 citations

T-cell-derived helper factor allows in vivo induction of cytotoxic T cells in nu/nu mice

1980 • 228 citations

TRANSFER OF A FUNCTIONING HUMORAL IMMUNE SYSTEM IN TRANSPLANTATION OF T-LYMPHOCYTE-DEPLETED BONE MARROW

1986 • 159 citations

Systemic administration of recombinant interleukin 2 stimulates in vivo lymphoid cell proliferation in tissues.

1985 • 136 citations

Features of T cells causing H-2-restricted lethal graft-vs.-host disease across minor histocompatibility barriers.

1982 • 121 citations

Defective interleukin 2 production in patients after bone marrow transplantation and in vitro restoration of defective T lymphocyte proliferation by highly purified interleukin 2

1984 • 97 citations

Nonspecific inhibitor released by T acceptor cells reduces the production of interleukin-2

1982 • 72 citations

Is immunological tolerance (non-responsiveness) a consequence of interleukin 2 deficit during the recognition of antigen?

1984 • 67 citations

IN VIVO ADMINISTRATION OF INTERLEUKIN-2 ENHANCES SPECIFIC ALLOIMMUNE RESPONSES

1983 • 58 citations

Immunological mechanisms of graft-versus-host disease in man.

1982 • 57 citations

Inhibiton of IL 2 production after human allogeneic bone marrow transplantation.

1983 • 53 citations

IMMUNOLOGICAL MECHANISMS OF GRAFT-VERSUS-HOST DISEASE IN MAN

1982 • 49 citations

Nonspecific inhibitor of DNA synthesis elaborated by T acceptor cells. I. Specific hapten- and I-J-driven liberation of an inhibitor of cell proliferation by Lyt-1-2+ cyclophosphamide-sensitive T acceptor cells armed with a product of Lyt-1+2+-specific suppressor cells.

1983 • 47 citations

Restoration of allograft responsiveness in B rats by interleukin 2 and/or adherent cells.

1982 • 31 citations

Production and response to interleukin 2 in vitro and in vivo after bone marrow transplantation in mice.

1985 • 17 citations

Immunogenetics of graft-versus-host reactions to minor histocompatibility antigens

1981 • 14 citations

Human urinary bladder carcinoma cell line (T24) in long-term culture: chromosomal studies on a wild population and derived sublines.

1977 • 14 citations

Cited By (0)

Loading...
T-cell depletion of allogeneic bone marrow prevents acceleration of graft-versus-host… (1986) – Cellular Immunology | Metascience Observatory Explorer